Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Leishmaniasis is one of the six major tropical diseases documented by WHO. Leishmaniasis is caused by infection with parasite protozoa Leishmania, and dogs harboring Leishmania act as reservoirs. There is presently no vaccine against leishmaniasis. We generated recombinant canine distemper viruses (rCDVs) that express Leishmania antigens or Th1 cytokine, and evaluated their protective efficacy against Leishmania challenge. As a result, the cocktail of three rCDVs expressing different antigens showed significant vaccine efficiency.
|